Poultry protection for sustainable industry
Poultry protection for sustainable industry
Paya Vaccine Company
Paya Vaccine Tavana, the Knowledge-based company, has started in Iran with a fully equipped production line, leverage cutting-edge global technologies, the highest international standards, and GMP principles and also relies on technical knowledge and experienced specialists, with the aim of developing and producing of poultry vaccines.
Paya Vaccine became operational by producing the crucial and strategic vaccine needed by Iran’s poultry industry and the international community under the brand name PayaVaxG79 (inactivated bivalent vaccine Newcastle virus genotype G7) and influenza virus (H9N2) and obtaining a production license from the Veterinary Organization.
Additionally, this company is expanding its range of products to meet the needs for poultry vaccines, food security, and a sustainable economy by acquiring the latest related technologies.
Mission
Paya Vaccine, a knowledge-based company, focuses on the main objectives of immunization, potency, and the effective efficacy of poultry veterinary vaccines by utilizing international technology standards and adhering to optimal GMP principles to ensure poultry health and prevent the spread of poultry diseases.
Vision
Paya Vaccine strives to become a leading company in producing and supplying the vaccines needed for the poultry industry, with adhering to the highest global and national standards and emphasizing maintaining the interests of its valued customers throughout Iran and the Middle East by 1405.
Paya Vaccine Company
Paya Vaccine Tavana, the Knowledge-based company, has started in Iran with a fully equipped production line, leverage cutting-edge global technologies, the highest international standards, and GMP principles and also relies on technical knowledge and experienced specialists, with the aim of developing and producing of poultry vaccines.
Paya Vaccine became operational by producing the crucial and strategic vaccine needed by Iran’s poultry industry and the international community under the brand name PayaVaxG79 (inactivated bivalent vaccine Newcastle virus genotype G7) and influenza virus (H9N2) and obtaining a production license from the Veterinary Organization.
Additionally, this company is expanding its range of products to meet the needs for poultry vaccines, food security, and a sustainable economy by acquiring the latest related technologies.
Mission
Paya Vaccine, a knowledge-based company, focuses on the main objectives of immunization, potency, and the effective efficacy of poultry veterinary vaccines by utilizing international technology standards and adhering to optimal GMP principles to ensure poultry health and prevent the spread of poultry diseases.
Vision
Paya Vaccine strives to become a leading company in producing and supplying the vaccines needed for the poultry industry, with adhering to the highest global and national standards and emphasizing maintaining the interests of its valued customers throughout Iran and the Middle East by 1405.
Paya Vaccine Tavana products
Paya Vaccine Company
Poultry protection for sustainable industry
The Best Technology for Enhanced Protection
Paya Vaccine Services
Paya Vaccine believes that a successful vaccination strategy plays a crucial role in the success of vaccines in protecting poultry, and also company provides comprehensive vaccination equipment along with trained expert to implement standard operational procedures for vaccination.
Support includes on-farm vaccination equipment supervision by vaccination experts to ensure proper vaccine application.
